Clinical and Genetic Features of Patients With Type 2 Diabetes and Renal Glycosuria

Role of the renal sympathetic nerve in renal glucose metabolism during the development of type 2 diabetes in rats

(2015) Kazi Rafiq et al.   DIABETOLOGIA

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

(2015) Bernard Zinman et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel Therapeutic Agent for Type 2 Diabetes Mellitus: SGLT2 Inhibitor

(2014) Chang Hee Jung et al.   Diabetes & Metabolism Journal

Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes

(2013) F. Cavalot   DIABETES OBESITY & METABOLISM

Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control

(2013) Donald E. Kohan et al.   KIDNEY INTERNATIONAL

The combination of carotid and lower extremity ultrasonography increases the detection of atherosclerosis in type 2 diabetes patients

(2012) Lianxi Li et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

A nutrient-sensitive interaction between Sirt1 and HNF-1α regulates Crp expression

(2010) Andrew A. Grimm et al.   AGING CELL

Mediators of sympathetic activation in metabolic syndrome obesity

(2008) Nora E. Straznicky et al.   CURRENT HYPERTENSION REPORTS